Psilos Group

Psilos Group was a prominent private equity firm established in 1998, based in New York City, with a dedicated focus on the healthcare sector. Over its active investment period, the firm specialized in growth equity and leveraged buyout transactions across various healthcare sub-sectors, including healthcare services, healthcare information technology, and medical devices. Psilos aimed to partner with management teams to scale innovative companies and drive value creation within the complex healthcare ecosystem.

The firm successfully raised multiple funds, demonstrating its capacity to attract significant institutional capital. One of its notable achievements was the closing of Psilos Group Partners IV, L.P. in 2008, which secured $525 million in commitments. This fund, like its predecessors, was deployed to support companies poised for substantial growth and transformation within healthcare. Psilos's investment philosophy often involved providing capital for expansion, strategic acquisitions, and operational improvements, leveraging its deep industry expertise and network.

However, Psilos Group appears to have transitioned into a legacy or harvesting phase and is no longer actively making new investments. Publicly available information, including their LinkedIn presence which shows no activity since 2014 and a defunct corporate website, suggests that the firm has ceased new deal sourcing. Many of the firm's former partners have since moved on to establish or join other prominent healthcare investment vehicles, indicating a strategic shift or wind-down of the original Psilos Group's active investment operations.

While Psilos Group historically played a significant role in fostering growth within the healthcare industry through its strategic investments and substantial capital deployment, its current status reflects a firm that has concluded its active investment cycle. As such, it is not currently seeking new portfolio companies or deploying fresh capital into the market.